Yes, some have but has anyone looked into what these drugs were bought for / licensed in for? Because that is what we really need to be looking at. You also need to be looking at the competition within each of those indications to compare apples to apples. PPS will not be the only player within the OA market. Anyway, everyone is free to take their own view, this is just my one. Best of luck to everyone on either side of the fence.
Ann: Paradigm (PAR) Updated Investor Presentation, page-19
Add PAR (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
27.0¢ |
Change
-0.010(3.57%) |
Mkt cap ! $82.30M | |||
| Open | High | Low | Value | Volume |
| 28.0¢ | 28.0¢ | 26.5¢ | $281.4K | 1.024M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 3499 | 27.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 28.0¢ | 161588 | 8 |
View Market Depth
| Last trade - 16.10pm 21/11/2024 (20 minute delay) ? |
| PAR (ASX) Chart |
